Inhibition of corneal fibrosis by topical application of blocking antibodies to TGF(β) in the rabbit

Cornea

Volumn 16, Issue 2, 1997, Pages 177-187

  Jester, James V ^a   Barry Lane, Patricia A ^a   Petroll, W Matthew ^a   Olsen, David R ^b   Cavanagh, H Dwight ^a  

^a UNIVERSITY OF TEXAS AT DALLAS   (United States)

^b Celtrix Pharmaceutical Co   (United States)

Author keywords

Blocking antibodies; Corneal fibrosis; Transforming growth factor 1

Indexed keywords

BLOCKING ANTIBODY; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORNEA; FIBROSIS; IMMUNOMODULATION; IMMUNOPATHOGENESIS; NONHUMAN; PRIORITY JOURNAL; RABBIT;

ADMINISTRATION, TOPICAL; ANIMALS; ANTIBODIES, BLOCKING; ANTIBODIES, MONOCLONAL; CELL DIVISION; CORNEA; CORNEAL TRANSPLANTATION; FIBRONECTINS; FIBROSIS; MICROSCOPY, CONFOCAL; MICROSCOPY, IMMUNOELECTRON; POSTOPERATIVE COMPLICATIONS; RABBITS; TRANSFORMING GROWTH FACTOR BETA; WOUND HEALING;

EID: 0030941193     PISSN: 02773740     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Roberts AB, Sporn MB. The transforming growth factors-β. In: Sporn MB, AB Roberts AB, eds. Peptide growth factors and their receptors. Berlin: Springer-Verlag, 1990:419-72.
2. Ohji M, SundarRaj N, Thoft RA. Transforming growth factor-β stimulates collagen and fibronectin synthesis by human corneal stromal fibroblasts in vitro. Curr Eye Res 1993;12: 703-9.
3. Jester JV, Barry-Lane PA, Cavanagh HD, Petroll WM. Inauction of α-smooth muscle actin expression and myofibroblast transformation in cultured corneal keratocytes. Cornea 1996;15:505-16.
4. Fini ME, Girard MT, Matsubara M, Bartlett JD. Unique regulation of the matrix metalloproteinase, gelatinase B. Invest Ophthalmol Vis Sci 1995;36:622-33.
5. Girard MT, Matsubara M, Fini ME. Transforming growth factor-β and interleukin-1 modulate metalloproteinase expression by corneal stromal cells. Invest Ophthalmol Vis Sci 1991;31:2441-54.
6. Grant MB, Khaw PT, Schultz GW, Adams JL, Shimizu RW. Effects of epidermal growth factor, fibroblast growth factor, and transforming growth factor-β on corneal cell chemotaxis. Invest Ophthalmol Vis Sci 1992;33:3292-301.
7. Wilson SE, He Y-G, Lloyd SA. EGF, EGF receptor, basic FGF, TGF beta-1, and IL-1 alpha mRNA in human corneal epithelial cells and stromal fibroblasts. Invest Ophthalmol Vis Sci 1992;33:1756-65.
8. Nishida K, Sotozono C, Adachi W, Yamamoto S, Yokoi N, Kinoshita S. Transforming growth factor-β 1, -β2 and -β3 mRNA expression in human cornea. Curr Eye Res 1995;14: 235-41.
9. Pasquale LR, Dorman-Pease E, Lutty GA, Quigley HA, Jampel HD. Immunolocalization of TGF-β1, TGF-β2 and TGF-β3 in the anterior segment of the human eye. Invest Ophthalmol Vis Sci 1993;34:23-30.
10. Wilson SE, Schultz GS, Chegini N, Weng J, He Y-G. Epidermal growth factor, transforming growth factor alpha, transforming growth factor beta, acidic fibroblast growth factor, basic fibroblast growth factor and interleukin-1 proteins in the cornea. Exp Eye Res 1994;59:63-72.
11. Nishida K, Kinoshita S, Yokoi N, Kaneda M, Hashimoto K, Yamamoto S. Immunohistochemical localization of transforming growth factor-β1, -β2 and -β3 latency-associated peptide in human cornea. Invest Ophthalmol Vis Sci 1994; 35:3289-94.
12. Desmouliere A, Rubbia-Brandt L, Abdiu A, Walz T, Macieira-Coelho A, Gabbiani G. α-Smooth muscle actin is expressed in a subpopulation of cultured and cloned fibroblasts and is modulated by γ-interferon. Exp Cell Res 1992;201:64-73.
13. Desmouliere A, Rubbia-Brandt L, Grau G, Gabbiani G. Heparin induces α-smooth muscle actin expression in cultured fibroblasts and in granulation tissue myofibroblasts. Lab Invest 1992;67:716-25.
14. Jester JV, Petroll WM, Barry PA, Cavanagh HD. Expression of α-actin during corneal stromal wound healing. Invest Ophthal Vis Sci 1995;36:809-19.
15. Ishizaki M, Zhy G, Haseba T, Shafer SS, Kao WW-Y. Expression of collagen I, smooth muscle α-actin, and vimentin during the healing of alkali-burned and lacerated corneas. Invest Ophthalmol Vis Sci 1994;34:3320-8.
16. Garana RMR, Petroll WM, Chen WT, et al. Radial keratotomy II: role of the myofibroblast in corneal wound contraction. Invest Ophthal Vis Sci 1992;33:3271-82.
17. Petroll WM, Cavanagh HD, Barry P, Andrews P, Jester JV. Quantitative analysis of stress fiber orientation during corneal wound contraction. J Cell Sci 1993;104:353-63.
18. Jester JV, Petroll WM, Barry PA, Cavanagh HD. Temporal, 3-dimensional cellular anatomy of corneal wound tissue. J Anat 1995;186:301-11.
19. Jester JV, Petroll WM, Feng W, Essepian J, Cavanagh HD. Radial keratotomy: I. The wound healing process and measurement of incisional gape in two animal models using in vivo, confocal microscopy. Invest Ophthalmol Vis Sci 1992; 33:3255-70.
20. Petroll WM, New KC, Sachdev M, Cavanagh HD, Jester JV. Radial keratotomy. III. Relationship between wound gape and corneal curvature in primate eyes. Invest Ophthalmol Vis Sci 1992;33:3283-91.
21. Petroll WM, Jester JV, Barry PA, Cavanagh HD. Assessment of F-actin organization and apical-basal polarity during in vivo cat endothelial wound healing. Invest Ophthalmol Vis Sci (in press).
22. Ichijima H, Ohashi J-I, Petroll WM, Cavanagh HD. Morphologic and biochemical evaluation of rigid gas permeable contact lens extended wear on rabbit corneal epithelium. CLAO J 1993;19:121-8.
23. Imayasu M, Petroll WM, Jester JV, Patel SK, Cavanagh HD. The relationship between contact lens oxygen transmissibility and binding of Pseudomonas aeruginosa to the cornea after overnight wear. Ophthalmology 1994;101:371-88.
24. Imayasu M, Moriyama T, Ichijima H, Ohashi J-I, Petroll WM, Jester JV, Cavanagh HD. The effects of daily wear of rigid gas permeable contact lenses treated with contact lens care solutions containing preservatives on the rabbit cornea. CLAO J 1994;20:183-8.
25. ARVO Statement for the Use of Animals in Ophthalmic and Vision Research. Invest Ophthalmol Vis Sci 1994;35:v-vi.
26. Dasch JR, Pace DR, Waegell W, Inenaga D, Ellingsworth L. Monoclonal antibodies recognizing transforming growth factor-β: bioactivity neutralization and transforming growth factor β2 affinity purification. J Immunol 1989;142:1536-41.
27. Jester JV, Petroll WM, Andrews P, Cavanagh HD, Lemp MA. In vivo confocal microscopy. J Electron Microsc Tech 1991;18:50-60.
28. Petroll WM, Cavanagh HD, Lemp MA, Andrews PM, Jester JV. In vivo digital imaging in confocal microscopy. J Microsc 1992;165:61-9.
29. Petroll WM, Jester JV, Cavanagh HD. Quantitative 3-dimensional confocal imaging of the cornea in situ and in vivo: system design and calibration. Scanning (in press).
30. Tuft SJ, Zabel RW, Marshall J. Corneal repair following keratectomy: a comparison between conventional surgery and laser photoablation. Invest Ophthalmol Vis Sci 1989;30: 1769-77.
31. 1,2 reduces cutaneous scarring in adult rodents. J Cell Sci 1994;106:1137-57.
32. 3 to cutaneous rat wounds reduces scarring. J Cell Sci 1995;108: 985-1002.
33. Tuft SJ, Fartry DS, Rawe IM, Meek KM. Photorefractive keratectomy: implications of corneal wound healing. Br J Ophthalmol 1993;77:243-7.
34. Morlet N, Gillies MC, Crouch R, Maloof A. Effect of topical interferon-alpha 2b on corneal haze after excimer laser photorefractive keratectomy in rabbits. Refract Corneal Surg 1993;9:443-51.
35. David T, Renard G, Hartmann C, Courtois Y, Pouliquen Y. Corneal wound healing modulation using basic fibroblast growth factor after excimer laser photorefractive keratectomy. Cornea 1995;14:227-34.
36. Petroll WM, Cavanagh HD, Jester JV. Three-dimensional imaging of corneal cells using in vivo confocal microscopy. J Microsc 1993;170:213-19.